Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Bpe02g02230 ATGGCTTATAATACGCTCTTTGTGCCTATGAAACTGCCTTCGAATTTTACGCAGTTAAGAAAATTGACTTATTTGTTTATGCGTCAATCAAATTTGATCGGTGGACTCCCCGAATCCATTGGAGACATGGCTGCTTTGGAGTTCTTGGATTTATCAGGCAATAGCTTAACCGGAAAGTTACCTAGTGGTCTGTTCACATTAAAGAATCTTAGTGAATTGTATTTGTTCAACAACCAACTGTCCGGCGAAATCCCCTCAGTAATTGAAACTACAAAGATAACGCAGCTCGATCTTTCCGAGAACAATTTGACAGGGACATTACCGGATGATTTTGGAAAGCTTCAGCTATTGACGAAGCTATCTTTGTTCATGAATCAATTTTCCGGTGAGATCCCACATAGCATCGGCCGTCTTCCTGCGCTGGTACTCCTAAAATTGTTCGACAACAATTTCTCCGGTGCATTGCCGGCTGATTTGGGGAGGTATTCAGCGCTCAAAATCCTCGACGTCGCAATAAACAGACTAACTGGAAGCATACCGGAGCACTTGTGCAGCGGCGGTGAGTTCGTCGGCTTGGCTGCTTATGGCAATAATCTTAGTGGAGGATTACCGAAATCTTTTGGAAACTGCAGTATATCAGCGAATCTTTCTCGATTGGAGATCAGCAACAACAAGTTTTCCGGGATCATTCCGCCACAGATATCATCTTGGAGAAACTTGCAGGTGTTCTTCGCGAGTAACAACCTACTTACAGGCCCAATTCCTCAAGAACTGACTTCTCTTCCAGCTCTGAACGCCCTTGTGCTTGATCAGAACCAGTTATCCGGCAACCTTCCGGTGGATAAAAGTTCATTAAAGTCATTAACTTTTCTTAACCTCAGCCATAATCAGCTCTCCGGAGAAATCCCAGAAGAAATTGGTCTTCTCCCAGATCTTACAGTTCTGGACCTATCCGTAAATCAATTTTCTGGGCAGATTCCGGCTCAACTTGGCCAGTTAATGTTCAATTTTCTTAATCTTTCTTCTAATCATCTTACAGGGATGATACCAACCGAGCTAGAAAACTCAGCTTATGATAACAGCTTCTTGAATAATCCTGGTCTTTGCTCAAGCAACTCACTTCTCAACATCAACGTCTGCAATTCACGACTGGAAAATTCGAGCAAACTATCTTCCCACCATCTAGCTTTGATCATAAGTTCAACAGTTGCAGTTTTTGTGTTATCAGTCATATGTTTACTCTTCCTGATCAGGTTCTACAAAAACAGAAATCTGGGAGTTGATTCGATATGGAAGTTGATGGCTTTCCAGAAGCTGAACTTTACAGAATCAACGATTTCATCAGGATTGACAGAGAAGAACCTTATCGGAAGTGGAGGATCCGGGAAAGTTTACCGTGTTCCGGTGAGTCTTCAGGACGATGTGGTTGCCGTGAAAAGGATATGGAATAACAGGAAAGTTGAGCAGAGATTGGAGAAACAATTCGTGGCGGAAGTTGAGATTCTGAGTTCAATCCGTCATTGCAACATAGTCAAGCTCCTCTGTGTTATTTCAAACGACAATACAAAGCTTCTGGTCTATGAATACCTGACGAACCAGAGCCTGGACAAATGGCTGCACAGAAAAACCAGACCCTCTGACTTCTCCGTTCTAGATTGGTCGAAGAGAATTCAGATTGCCGTGGGAGCTGCCAGAGGTCTCTGTTACATGCACTTTGACTGCTCTCCTCCTGTAATTCATCGAGACTTGAAATCCAGCAACATTTTATTGGATTCAGAATTCCGCGCAAAAATTGCAGATTTCGGTCTTGCCCAGATCTTAATCAAGCAAGGTGAAGCCGTAACAATGTCCGCCGTAGCTGGCTCCTTCGGCTACATAGCGCCAGAATATGCTCAGACTACGAGGGTAAACGAGAAAATTGACGTCTACAGCTTTGGAGTAATTCTCTTAGAGCTTGTGACCGGAAAAGAAGCCCATGATGGAGACGAAAGCACTAACCTTGCAGATTGGGCGTGGCGCCATATTCGGGGGGGTAAAGCCATTGTAGAAGCTCTGGACGAGGAAATAAAAGAGCCACTTTATGTCGAAGAAATGAGCTGTGTTTTTAAGCTTGGGATATTATGCACAGCTACTCAGCCCTCCTCGAGGCCTTCCATGAAAGATGTTCTGCAAATACTCCAACGCTTATCACCAATGTTATCAGCATCAACGTATCCATCCAAGTCCAAGTCTGACTTTCGAAAACATAAAGCGAACCCCGAACTACCCTACAAGTATCGCAAGATCCACTTTACGGTTTACCAATGTTTCCTTTTTGAATTACTCATAAATTTTTTTACAACTCCCACTGCATGTGTAATATCTGGTCGCGTGCAAACCATCGCGTACATAAGACTACTAACAGCAGAGGCATATGAAACAGTTGATTCCCAGCTCTGTGATCAAGAGTATGATGTCCTCCTATCGCTTAAGGAATTCTGGAAAGATCCTCCGGCGATTAGTTATTGGAGTTCAACAACCGGTTCTCACTGTAGCTGGGATGATATCCGATGCACTAATAACTCCGTCACCTTCCTTTCTCCTGTTAGTAAGAACATCACCGATATAATTCCTTTCTTCATTTCTGATCTTCGAATTCTCACTTTTCTCAATCTGAGTTGGAATTACATACCTGGTGGATTTCCTCGAGTGCTTTACAATAGTACTAAGCTTCAGTTCTTGGATCTTTCTCATAATTATTTTGTTCGTCCCATTCCCGAGGATGTTGATCGATTAAATCGTCTTCAACATCTGAACCTTTCCGCCAACAACTTCTCCGGCGAACTCCCCGAATCAATTGGAAACATGGCTGCTTTGGAGTTCTTGGATTTATCCGGCAATAGTTTAACCGGAAAGTTACCGAGTGGTTTGTTCACATTGAAGAATCTCAGTGAATTGTATTTGTACAACAACCATCTGTCCGGCGAAATCCCCTCATTAATTGAAACTACAAAGATAACGCAGCTCGATATTTCCGGGAACAAGTTGGCAGGGATATTACCGGCTGATTTTGGAAAGCTTCAGCTATTGACGAAGCTATCTTTGTTCATGAATCAATTTTCCGGTGAGATTCCACATAGCATCGGCTGTCTTCCTGCGTTAATATTCCTAAAATTGTTGGACAACAGTTTCTCCGGCGCATTGTCTCCTGATTTGGGGAGATATTCAGCGCTCAAAATCCTCGACGTCGCAAAAAACAGACTAACTGGAAGCCCACCGGAGCACTTGTGCAGCGGCGGTGAGTTAGGCGCTTTGGCAGCTTACGACAATAATCTTAGTGGAGAACTACCAAAATCCTTTGGAAACTGCAGTAGTTTGTATATCGTCAATGTATATAATAATAACTTGTCCGGCAAACCTCCCAGCGGTTTTTGGACTTCGTTAAATCTCACCACAATCCTTCTATACAACAATTCTCTCACTGGCGAGCTTCCGGCGCGAGTATCAGCGAATCTTTCTCGATTGGAGATCAGCAACAAGAAGTTTTCCGGGATCATTCCGCCACAGATATCATCTTGGAGAAACTTGCTGGTGTTCTTCGCGAGTAACAACCTACTTACAGGCCCAATTCCTCAAGAACTGACTTCTCTTCCAGCTCTGAACGCCCTTGCGCTTGATCAGAACCAGTTATCCGGCAACCTTCCGGTGGATTTAACTTTTCTTAACCTCAGCCATAATCAGCTCTCCGAAGAAATCCCAGAAGAAATTGCTCTTCTTCCAGATCTTAAAGTTCTGGACCTATCCGTAAATCAATTCTCTGGGCAGATTCCGGCTCAACTTGGCCAATTAATGTTCAATTTTCTTAATCTTTCTTCTAATCATCTTACAGGGATGATACCAACCGAGCTAGAAAACTCAGCTTATGATAACAGCTTCTTGAATAATCTTGGTCTGTGCTCAAGCAACTCACTTCTCAACATCAACGTCTGCAATTCTCGACTGGAAAATTCGAGCAAACTATCTTCCCACCATCTAGCTTTAATCACAAGTTCAACAGTTGCAGTTTTTGTTTTATCAGTCATATGTTTACTCTTCCTGATCAAGTTCTACAAAAAAAGAAATCCGGGAGTTGATTCGATATGGAAGTTGACGGCTTTCCAGAAGCTGAACTTTACAGAATCAACGATTTCATCAAGATCGACAGAGAAGAACCTTATCGGAAGTGGAGGATCCGGGAAAGTTTACCGTGTTCCGGTGAGTCTTCAGGACGATGTGGTTGCCGTGAAAAGGATATGGAATAACAGGAAAGTTGAGCAGAGATTGGAGAAACAATTCATGGCGGAAGTTGAGATTCTGAGTTCAATCCGCCATTGCAACATAGTCAAGCTCCTCTGCGTTAGTTCAAACGACAATACAAAGCTTCTGGTCTATGAATACCTGACGAACCAGAGCCTGGACAAATGGCACAGAAAAACCAAACCATCTGACTTCTCCGTTCTAGATTGGTCGAAGAGAATTCAGATTGCCGTGGGAGCTGCCAGAGGCCTCTGTTACATGCACTATGACTGCTCTCCTCCTGTAATTCATCGAGACTTGAAATCCAGCAACATTTTATTGGATTCAGAATTCCGCGCAAAAATTGCAGATTTTGGTCTTGCCCAGATCTTAATCAAGCAAGGTGAAGCCGTAACAATGTCCGCCGTAGCTGGCTCTTTCGGCTACATAGCGCCAGAATATGCTCAGACTACGAGGGTAAACGAGAAAATTGACGTCTACAGCTTTGGAGTAATTCTCTTAGAGCTTGTGACCGGAAAAGAAGCCCATGATGGAGACGAAAGCACTAACCTTGCAGATTGGGCGTGGCGCCATATTCGGGGGGGTAAAGCCATTGTAGAAGCTCTGGACGAGGAAATAAAAGAGCCACTCAGCCCTCCTCGAGGCCTTCCATGA 4929 43.62 MAYNTLFVPMKLPSNFTQLRKLTYLFMRQSNLIGGLPESIGDMAALEFLDLSGNSLTGKLPSGLFTLKNLSELYLFNNQLSGEIPSVIETTKITQLDLSENNLTGTLPDDFGKLQLLTKLSLFMNQFSGEIPHSIGRLPALVLLKLFDNNFSGALPADLGRYSALKILDVAINRLTGSIPEHLCSGGEFVGLAAYGNNLSGGLPKSFGNCSISANLSRLEISNNKFSGIIPPQISSWRNLQVFFASNNLLTGPIPQELTSLPALNALVLDQNQLSGNLPVDKSSLKSLTFLNLSHNQLSGEIPEEIGLLPDLTVLDLSVNQFSGQIPAQLGQLMFNFLNLSSNHLTGMIPTELENSAYDNSFLNNPGLCSSNSLLNINVCNSRLENSSKLSSHHLALIISSTVAVFVLSVICLLFLIRFYKNRNLGVDSIWKLMAFQKLNFTESTISSGLTEKNLIGSGGSGKVYRVPVSLQDDVVAVKRIWNNRKVEQRLEKQFVAEVEILSSIRHCNIVKLLCVISNDNTKLLVYEYLTNQSLDKWLHRKTRPSDFSVLDWSKRIQIAVGAARGLCYMHFDCSPPVIHRDLKSSNILLDSEFRAKIADFGLAQILIKQGEAVTMSAVAGSFGYIAPEYAQTTRVNEKIDVYSFGVILLELVTGKEAHDGDESTNLADWAWRHIRGGKAIVEALDEEIKEPLYVEEMSCVFKLGILCTATQPSSRPSMKDVLQILQRLSPMLSASTYPSKSKSDFRKHKANPELPYKYRKIHFTVYQCFLFELLINFFTTPTACVISGRVQTIAYIRLLTAEAYETVDSQLCDQEYDVLLSLKEFWKDPPAISYWSSTTGSHCSWDDIRCTNNSVTFLSPVSKNITDIIPFFISDLRILTFLNLSWNYIPGGFPRVLYNSTKLQFLDLSHNYFVRPIPEDVDRLNRLQHLNLSANNFSGELPESIGNMAALEFLDLSGNSLTGKLPSGLFTLKNLSELYLYNNHLSGEIPSLIETTKITQLDISGNKLAGILPADFGKLQLLTKLSLFMNQFSGEIPHSIGCLPALIFLKLLDNSFSGALSPDLGRYSALKILDVAKNRLTGSPPEHLCSGGELGALAAYDNNLSGELPKSFGNCSSLYIVNVYNNNLSGKPPSGFWTSLNLTTILLYNNSLTGELPARVSANLSRLEISNKKFSGIIPPQISSWRNLLVFFASNNLLTGPIPQELTSLPALNALALDQNQLSGNLPVDLTFLNLSHNQLSEEIPEEIALLPDLKVLDLSVNQFSGQIPAQLGQLMFNFLNLSSNHLTGMIPTELENSAYDNSFLNNLGLCSSNSLLNINVCNSRLENSSKLSSHHLALITSSTVAVFVLSVICLLFLIKFYKKRNPGVDSIWKLTAFQKLNFTESTISSRSTEKNLIGSGGSGKVYRVPVSLQDDVVAVKRIWNNRKVEQRLEKQFMAEVEILSSIRHCNIVKLLCVSSNDNTKLLVYEYLTNQSLDKWHRKTKPSDFSVLDWSKRIQIAVGAARGLCYMHYDCSPPVIHRDLKSSNILLDSEFRAKIADFGLAQILIKQGEAVTMSAVAGSFGYIAPEYAQTTRVNEKIDVYSFGVILLELVTGKEAHDGDESTNLADWAWRHIRGGKAIVEALDEEIKEPLSPPRGLP 1642
       

Gff information

Chromosome Start End Strand Old_gene Gene Num
2 23295622 23311043 - Bpe010047.1 Bpe02g02230 100379
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Bpe02g02230 1642 PANTHER RECEPTOR-LIKE PROTEIN KINASE HSL1 212 742 - -
Bpe02g02230 1642 PANTHER RECEPTOR-LIKE PROTEIN KINASE HSL1 1 211 - -
Bpe02g02230 1642 PANTHER RECEPTOR-LIKE PROTEIN KINASE HSL1 803 949 - -
Bpe02g02230 1642 PANTHER RECEPTOR-LIKE PROTEIN KINASE HSL1 937 1635 - -
Bpe02g02230 1642 SUPERFAMILY L domain-like 838 1158 - -
Bpe02g02230 1642 Pfam Leucine rich repeat N-terminal domain 814 851 IPR013210 -
Bpe02g02230 1642 ProSiteProfiles Protein kinase domain profile. 450 733 IPR000719 GO:0004672|GO:0005524|GO:0006468
Bpe02g02230 1642 SUPERFAMILY L domain-like 12 279 - -
Bpe02g02230 1642 Pfam Leucine Rich repeat 286 301 IPR001611 GO:0005515
Bpe02g02230 1642 Gene3D Ribonuclease Inhibitor 91 381 IPR032675 -
Bpe02g02230 1642 Gene3D Ribonuclease Inhibitor 813 967 IPR032675 -
Bpe02g02230 1642 Gene3D Ribonuclease Inhibitor 2 90 IPR032675 -
Bpe02g02230 1642 SUPERFAMILY L domain-like 283 350 - -
Bpe02g02230 1642 PANTHER RECEPTOR KINASE-LIKE PROTEIN XA21 212 742 - -
Bpe02g02230 1642 PANTHER RECEPTOR KINASE-LIKE PROTEIN XA21 1 211 - -
Bpe02g02230 1642 PANTHER RECEPTOR KINASE-LIKE PROTEIN XA21 803 949 - -
Bpe02g02230 1642 PANTHER RECEPTOR KINASE-LIKE PROTEIN XA21 937 1635 - -
Bpe02g02230 1642 SUPERFAMILY Protein kinase-like (PK-like) 1386 1618 IPR011009 -
Bpe02g02230 1642 ProSiteProfiles Leucine-rich repeat profile. 1230 1252 IPR001611 GO:0005515
Bpe02g02230 1642 SUPERFAMILY RNI-like 1069 1310 - -
Bpe02g02230 1642 Gene3D Ribonuclease Inhibitor 1162 1231 IPR032675 -
Bpe02g02230 1642 Gene3D Ribonuclease Inhibitor 1232 1309 IPR032675 -
Bpe02g02230 1642 SMART LRR_typ_2 949 973 IPR003591 -
Bpe02g02230 1642 SMART LRR_typ_2 138 162 IPR003591 -
Bpe02g02230 1642 SMART LRR_typ_2 285 308 IPR003591 -
Bpe02g02230 1642 SMART LRR_typ_2 309 333 IPR003591 -
Bpe02g02230 1642 SMART LRR_typ_2 925 948 IPR003591 -
Bpe02g02230 1642 SMART LRR_typ_2 43 67 IPR003591 -
Bpe02g02230 1642 SMART LRR_typ_2 1252 1276 IPR003591 -
Bpe02g02230 1642 ProSitePatterns Protein kinases ATP-binding region signature. 456 479 IPR017441 GO:0005524
Bpe02g02230 1642 ProSiteProfiles Leucine-rich repeat profile. 287 309 IPR001611 GO:0005515
Bpe02g02230 1642 ProSiteProfiles Leucine-rich repeat profile. 975 997 IPR001611 GO:0005515
Bpe02g02230 1642 Pfam Protein kinase domain 451 724 IPR000719 GO:0004672|GO:0005524|GO:0006468
Bpe02g02230 1642 Pfam Protein kinase domain 1395 1618 IPR000719 GO:0004672|GO:0005524|GO:0006468
Bpe02g02230 1642 Gene3D Phosphorylase Kinase; domain 1 434 529 - -
Bpe02g02230 1642 ProSitePatterns Serine/Threonine protein kinases active-site signature. 1520 1532 IPR008271 GO:0004672|GO:0006468
Bpe02g02230 1642 PRINTS Leucine-rich repeat signature 285 298 - -
Bpe02g02230 1642 PRINTS Leucine-rich repeat signature 93 106 - -
Bpe02g02230 1642 SMART serkin_6 450 733 IPR000719 GO:0004672|GO:0005524|GO:0006468
Bpe02g02230 1642 SMART serkin_6 1393 1636 IPR000719 GO:0004672|GO:0005524|GO:0006468
Bpe02g02230 1642 Pfam Leucine rich repeat 927 986 IPR001611 GO:0005515
Bpe02g02230 1642 Pfam Leucine rich repeat 215 274 IPR001611 GO:0005515
Bpe02g02230 1642 ProSitePatterns Protein kinases ATP-binding region signature. 1399 1422 IPR017441 GO:0005524
Bpe02g02230 1642 SUPERFAMILY Protein kinase-like (PK-like) 439 727 IPR011009 -
Bpe02g02230 1642 Gene3D Phosphorylase Kinase; domain 1 1372 1472 - -
Bpe02g02230 1642 ProSitePatterns Serine/Threonine protein kinases active-site signature. 578 590 IPR008271 GO:0004672|GO:0006468
Bpe02g02230 1642 Gene3D Transferase(Phosphotransferase) domain 1 1473 1639 - -
Bpe02g02230 1642 Gene3D Transferase(Phosphotransferase) domain 1 530 750 - -
Bpe02g02230 1642 Gene3D Ribonuclease Inhibitor 968 1161 IPR032675 -
Bpe02g02230 1642 ProSiteProfiles Protein kinase domain profile. 1393 1642 IPR000719 GO:0004672|GO:0005524|GO:0006468
       

Duplication type information

Select Gene1 Location1 Gene2 Location2 E-value Duplicated-type
Bpe02g02230 Bpe-Chr2:23295622 Bpe02g01660 Bpe-Chr2:19299744 3.86E-13 dispersed
Bpe02g02230 Bpe-Chr2:23295622 Bpe10g00026 Bpe-Chr10:386710 1.26E-17 transposed
       

Transcription factors information

Select Gene Hmm_acc Hmm_name Score E-value Regulatory Factors Family
63211 PF00069 Pkinase 9.60E-48 CL0016 Bpe PK
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Bpe02g02230 - - cam:101515509 1290.4